Renovaro Biosciences (RENB) Short Term Debt

Annual Short Term Debt

$2.94 M
-$1.87 M-38.89%

June 30, 2024


Summary


Performance

RENB Short Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRENBbalance sheetmetrics:

Quarterly Short Term Debt

$3.11 M
+$166.50 K+5.65%

September 30, 2024


Summary


Performance

RENB Quarterly Short Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRENBbalance sheetmetrics:

Short Term Debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

RENB Short Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-38.9%-19.8%
3 y3 years+907.0%-19.8%
5 y5 years+100.0%-19.8%

RENB Short Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-38.9%+907.0%-59.1%+122.4%
5 y5-year-38.9%-100.0%-59.1%+1091.5%
alltimeall time-38.9%-100.0%-59.1%-100.0%

Renovaro Biosciences Short Term Debt History

DateAnnualQuarterly
Sep 2024
-
$3.11 M(+5.7%)
Jun 2024
$2.94 M(-38.9%)
$2.94 M(-61.3%)
Mar 2024
-
$7.60 M(+13.0%)
Dec 2023
-
$6.73 M(+73.5%)
Sep 2023
-
$3.88 M(-19.5%)
Jun 2023
$4.82 M(+231.5%)
-
Jun 2023
-
$4.82 M(-22.4%)
Mar 2023
-
$6.21 M(+25.9%)
Dec 2022
-
$4.93 M(+252.4%)
Sep 2022
-
$1.40 M(-3.8%)
Jun 2022
$1.45 M(+397.1%)
$1.45 M(-76.9%)
Mar 2022
-
$6.28 M(+24.8%)
Dec 2021
-
$5.03 M(+1588.9%)
Sep 2021
-
$297.90 K(+1.9%)
Jun 2021
$292.40 K(+7.8%)
$292.40 K(+1.9%)
Mar 2021
-
$287.00 K(+1.9%)
Dec 2020
-
$281.70 K(+1.9%)
Sep 2020
-
$276.50 K(+1.9%)
Jun 2020
$271.30 K(>+9900.0%)
$271.30 K(+1.9%)
Mar 2020
-
$266.20 K(+2.0%)
Dec 2019
-
$261.10 K(+2.0%)
Sep 2019
-
$256.10 K(>+9900.0%)
Jun 2019
$0.00
$0.00(-100.0%)
Dec 2017
-
$209.30 K(-57.8%)
DateAnnualQuarterly
Sep 2017
-
$496.00 K(-76.3%)
Jun 2017
$2.09 M(+1930.9%)
$2.09 M(+374.8%)
Mar 2017
-
$440.10 K(+326.5%)
Dec 2016
-
$103.20 K(-0.3%)
Sep 2016
-
$103.50 K(+0.6%)
Jun 2016
$102.90 K(+2.3%)
$102.90 K(+0.2%)
Mar 2016
-
$102.70 K(+1.3%)
Dec 2015
-
$101.40 K(+0.2%)
Sep 2015
-
$101.20 K(+1.9%)
Jun 2015
$100.60 K(+0.6%)
-
Mar 2015
-
$99.30 K(-0.7%)
Dec 2014
$100.00 K(+57.0%)
$100.00 K(-93.8%)
Sep 2014
-
$1.61 M(-6.2%)
Jun 2014
-
$1.72 M(+0.7%)
Mar 2014
-
$1.71 M(+2103.1%)
Dec 2013
-
$77.40 K(+5.0%)
Sep 2013
-
$73.70 K(+14.8%)
Jun 2013
-
$64.20 K(+0.8%)
Mar 2013
$63.70 K(+134.2%)
$63.70 K(+16.5%)
Dec 2012
-
$54.70 K(+507.8%)
Sep 2012
-
$9000.00(+80.0%)
Jun 2012
-
$5000.00(-81.6%)
Mar 2012
$27.20 K
$27.20 K(+444.0%)
Dec 2011
-
$5000.00

FAQ

  • What is Renovaro Biosciences annual short term debt?
  • What is the all time high annual short term debt for Renovaro Biosciences?
  • What is Renovaro Biosciences annual short term debt year-on-year change?
  • What is Renovaro Biosciences quarterly short term debt?
  • What is the all time high quarterly short term debt for Renovaro Biosciences?
  • What is Renovaro Biosciences quarterly short term debt year-on-year change?

What is Renovaro Biosciences annual short term debt?

The current annual short term debt of RENB is $2.94 M

What is the all time high annual short term debt for Renovaro Biosciences?

Renovaro Biosciences all-time high annual short term debt is $4.82 M

What is Renovaro Biosciences annual short term debt year-on-year change?

Over the past year, RENB annual short term debt has changed by -$1.87 M (-38.89%)

What is Renovaro Biosciences quarterly short term debt?

The current quarterly short term debt of RENB is $3.11 M

What is the all time high quarterly short term debt for Renovaro Biosciences?

Renovaro Biosciences all-time high quarterly short term debt is $7.60 M

What is Renovaro Biosciences quarterly short term debt year-on-year change?

Over the past year, RENB quarterly short term debt has changed by -$765.80 K (-19.75%)